Health

New Alzheimer’s drug clears abnormal protein clogs in small, promising trial

By Karen Weintraub, Scientific American

Aducanumab, a new drug that some researchers are calling the most promising yet in the fight against Alzheimer’s, suggests it is possible to clear the brain of the amyloid protein, a characteristic of the disease.

Baltimore unveils its plan to cut health disparities by 50 percent in a decade

By Jay Hancock, Kaiser Health News

Violence last year following the death of Freddie Gray, a black man who died after being injured in police custody, exposed Baltimore’s health divide as well as its criminal justice differences, officials said. Gray’s family had won a settlement for…

82 cases of Zika emerge from Singapore’s local outbreak in less than a week

By Eugene Mason

Since announcing the first locally transmitted case on Saturday, health officials have uncovered dozens of Zika cases in Singapore without links to travel.

Zika stays in the family, mother mosquitoes pass virus to eggs

By Nsikan Akpan

The inheritance of Zika virus may guarantee its long-term survival in mosquito (and human) populations.

Has overmedicating seniors become ‘America’s other drug problem’?

By Anna Gorman, Kaiser Health News

An increasing number of elderly patients nationwide are on multiple medications to treat chronic diseases, raising their chances of dangerous drug interactions and serious side effects. Often the drugs are prescribed by different specialists who don’t communicate with each other.

Did outcry on social media lead to Mylan’s generic EpiPen?

By PBS News Hour

After news broke that the price of EpiPen injectors has skyrocketed, the allergy medicine’s maker, Mylan, announced its intention to offer a generic version of the product, to be sold at half the market price of the original. The New…

Continue watching

EpiPen drugmaker announces generic version to cost half the price

By News Desk

Identical to the original product -- a pre-filled syringe containing epinephrine, used for life-threatening allergic reactions -- the generic will cost $300 for two.

Gender inequality is a $95 billion issue in sub-Saharan Africa

By Daniel Moritz-Rabson

Gender inequality costs sub-Saharan Africa an average of $95 billion each year according to an annual United Nations Development Programme report published Sunday.

Can Clinton save health overhaul from its mounting problems?

By Ricardo Alonso-Zaldivar, Associated Press

With the hourglass running out for his administration, President Barack Obama's health care law is struggling in many parts of the country.

Genetically modified mosquitoes have wide support in Florida

By Helen Branswell, STAT

Most people in Florida — the first US state to experience local spread of the Zika virus — favor the use of genetically modified mosquitoes to combat spread of the virus, a new poll suggests.